Moderna's experimental coronavirus vaccine was highly effective at preventing COVID-19, the Massachusetts biotech company said on Monday.The announcement closely follows similar news from a rival vaccine program by Pfizer and BioNTech, which touted late-stage success a week ago.
The impact from these scientific successes won't be immediate. Both vaccine candidates still need to secure regulatory approval, and initial supply will be extremely limited.
Sold shares on Friday 😡
Can we have a video of this topic
Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite: